The second revolution in gene therapy that has cured Javier, a child with a lethal error in the X chromosome
By Oriol Güell,
El País
| 02. 17. 2025
A “small strand of blood in the poop.” This was the first sign, initially viewed as unimportant, that put Jesús Lunar and Cristina López on the trail that something was happening with their son’s health. Javier had been born on June 12, 2020, and before the discovery, which occurred a few days later, everything had been following the chaotic routines that new members of any family impose. Six months later, however, the doctors sat the couple down and gave them the news that was going to change their lives.
“We were told that Javier had Wiskott-Aldrich syndrome, a rare genetic disease that affects the immune system. At first we didn’t know how to react, it was hard for us to accept that it could be fatal. But then something in your head clicks. You tell yourself that you have to keep going and that everything that needs to be done will be done. And so it has been to this day,” says this computer programmer born in 1982.
Javier is almost five years old now and, apart from some minor...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Rob Stein, NPR | 04.23.2026
The Food and Drug Administration approved the first gene therapy to restore hearing for people who were born deaf.
The decision, while only immediately affecting people born with a very rare form of genetic deafness, is being hailed as...
By Emily Mullin, Wired | 04.23.2026
A STARTUP OUT of Utah, Paterna Biosciences, says it has successfully grown functional human sperm in a lab and used the sperm to make visibly healthy-looking embryos. The technique could eventually help men with certain types of infertility have biological children...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...